Tomuzotuximab Biosimilar - Research Grade

Human

EGFRï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P00533;P00533;Q01279;Q01279;P00533

Blue ice

EGFR drives proliferative and survival signaling and is among the most studied oncogenic receptors in epithelial cancer research. Offered here is a research-grade, unconjugated analog of tomuzotuximab, a recombinant anti-EGFR monoclonal antibody for research use only. It is manufactured to in vivo standards in a low-endotoxin format and made in scalable milligram to gram quantities for high-throughput laboratories. The antibody supports receptor-blockade functional assays, in vitro EGFR-signaling and ADCC screens, and in vivo tumor models exploring growth-factor pathways. Dependable lot-to-lot consistency underpins reliable use across large and repeated experiments. Its reproducible formulation and scalable volumes support standardized results in bulk research.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks